Literature DB >> 32088752

Strategies for implementation of guideline recommended cardiovascular risk management for patients with rheumatoid arthritis: results from a questionnaire survey of expert rheumatology centers.

Julia M Weijers1, Anne G Semb2, Silvia Rollefstad2, George D Kitas3, Piet L C M van Riel4,5.   

Abstract

The aim was to study the different strategies used to implement cardiovascular risk evaluation and management for patients with rheumatoid arthritis (RA) in daily clinical practice. A questionnaire survey was performed among both the members of the international Trans-Atlantic Cardiovascular Risk Consortium for Rheumatoid Arthritis (ATACC-RA) as well as the Survey of cardiovascular disease risk factors (CVD-RF) in patients with RA (SURF-RA) group. The questionnaire included 18 questions with the overarching topics: (1) organization and responsibility of cardiovascular risk management (CVRM); (2) screening of CVD-RFs; (3) overview current CVRM status; and (4) availability of data regarding CVRM. Based on the answers, two researchers (JW, PR) independently categorized the different strategies. Thirteen out of 27 rheumatology centers responded to the questionnaire. One rheumatology center did not have organized CVRM for their RA patients. Among the other centers, three strategies to organize CVRM in daily practice were distinguished: (1) the rheumatologist performs CVRM during outpatient visits (n = 6); (2) cardiologists and rheumatologists co-operate in a cardio-rheuma-clinic/team with different tasks and responsibilities (n = 3); and (3) the general practitioner screens and intervenes on CVD-RFs (n = 3). Each CVRM strategy was based on agreements between medical professionals and was also dependent on the national healthcare system and available financial resources. Three strategies were identified for CVRM implementation in daily clinical practice based on who is primarily responsible for performing CVRM. More research is warranted to compare their relative merits and effectiveness in relation to CVRM.

Entities:  

Keywords:  Cardiovascular diseases; Guideline adherence; Organization; Rheumatoid arthritis

Mesh:

Year:  2020        PMID: 32088752     DOI: 10.1007/s00296-020-04533-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  16 in total

1.  Quality of care for cardiovascular disease prevention in rheumatoid arthritis: compliance with hyperlipidemia screening guidelines.

Authors:  Timothy J Schmidt; J Antonio Aviña-Zubieta; Eric C Sayre; Michal Abrahamowicz; John M Esdaile; Diane Lacaille
Journal:  Rheumatology (Oxford)       Date:  2018-10-01       Impact factor: 7.580

2.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Authors:  M J L Peters; D P M Symmons; D McCarey; B A C Dijkmans; P Nicola; T K Kvien; I B McInnes; H Haentzschel; M A Gonzalez-Gay; S Provan; A Semb; P Sidiropoulos; G Kitas; Y M Smulders; M Soubrier; Z Szekanecz; N Sattar; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2009-09-22       Impact factor: 19.103

3.  Dyslipidemia and rheumatoid arthritis.

Authors:  R D Situnayake; G Kitas
Journal:  Ann Rheum Dis       Date:  1997-06       Impact factor: 19.103

4.  Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies.

Authors:  Juan Antonio Avina-Zubieta; Jamie Thomas; Mohsen Sadatsafavi; Allen J Lehman; Diane Lacaille
Journal:  Ann Rheum Dis       Date:  2012-03-16       Impact factor: 19.103

5.  2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.

Authors:  Alberico L Catapano; Ian Graham; Guy De Backer; Olov Wiklund; M John Chapman; Heinz Drexel; Arno W Hoes; Catriona S Jennings; Ulf Landmesser; Terje R Pedersen; Željko Reiner; Gabriele Riccardi; Marja-Riita Taskinen; Lale Tokgozoglu; W M Monique Verschuren; Charalambos Vlachopoulos; David A Wood; Jose Luis Zamorano; Marie-Therese Cooney
Journal:  Eur Heart J       Date:  2016-08-27       Impact factor: 29.983

6.  Gaps in Addressing Cardiovascular Risk in Rheumatoid Arthritis: Assessing Performance Using Cardiovascular Quality Indicators.

Authors:  Claire E H Barber; John M Esdaile; Liam O Martin; Peter Faris; Cheryl Barnabe; Selynne Guo; Elena Lopatina; Deborah A Marshall
Journal:  J Rheumatol       Date:  2016-08-01       Impact factor: 4.666

7.  Cardiovascular risk management in rheumatoid arthritis: A large gap to close.

Authors:  Karim Ladak; Jomana Hashim; Matthew Clifford-Rashotte; Vikas Tandon; Mark Matsos; Ameen Patel
Journal:  Musculoskeletal Care       Date:  2017-04-18

8.  All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database.

Authors:  Douglas J Watson; Thomas Rhodes; Harry A Guess
Journal:  J Rheumatol       Date:  2003-06       Impact factor: 4.666

Review 9.  Implementation of the EULAR cardiovascular risk management guideline in patients with rheumatoid arthritis: results of a successful collaboration between primary and secondary care.

Authors:  Julia M Weijers; Sanne A A Rongen-van Dartel; Dan M G M F Hoevenaars; Max Rubens; Marlies E J L Hulscher; Piet L C M van Riel
Journal:  Ann Rheum Dis       Date:  2017-11-22       Impact factor: 19.103

10.  Practice what you preach? An exploratory multilevel study on rheumatoid arthritis guideline adherence by rheumatologists.

Authors:  N Lesuis; A A den Broeder; M E J L Hulscher; R F van Vollenhoven
Journal:  RMD Open       Date:  2016-05-17
View more
  4 in total

1.  Cardiology co-management of rheumatoid arthritis patients with coronary artery disease as an intervention reduces hospitalization rates and adverse event occurrence.

Authors:  Jorge D Guerra; Andres Belmont De Santiago; Shirley Reed; Kendall P Hammonds; Courtney Shaver; Robert J Widmer; Beth A Scholz
Journal:  Clin Rheumatol       Date:  2022-08-16       Impact factor: 3.650

2.  Joint Destruction Is Associated With All Types of Cardiovascular Events in French Rheumatoid Patients: A Real-Life Study With Very Long Follow-Up.

Authors:  Marie Robert; Arnaud Hot; François Mifsud; Ndiémé Ndongo-Thiam; Pierre Miossec
Journal:  Front Med (Lausanne)       Date:  2020-10-30

Review 3.  Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment.

Authors:  Anne Mirjam Kerola; Silvia Rollefstad; Anne Grete Semb
Journal:  Eur Cardiol       Date:  2021-05-13

4.  Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit.

Authors:  Anne Grete Semb; Silvia Rollefstad; Eirik Ikdahl; Grunde Wibetoe; Joseph Sexton; Cindy Crowson; Piet van Riel; George Kitas; Ian Graham; Solbritt Rantapää-Dahlqvist; George Athanasios Karpouzas; Elena Myasoedova; Miguel A Gonzalez-Gay; Petros P Sfikakis; Maria G Tektonidou; Argyro Lazarini; Dimitrios Vassilopoulos; Bindee Kuriya; Carol Hitchon; Maria Simona Stoenoiu; Patrick Durez; Virginia Pascual-Ramos; Dionicio Angel Galarza-Delgado; Pompilio Faggiano; Durga Prasanna Misra; Andrew A Borg; Rong Mu; Erkin M Mirrakhimov; Diane Gheta; Karen Douglas; Vikas Agarwal; Svetlana Myasoedova; Lev Krougly; Tatiana Valentinovna Popkova; Alena Tuchyňová; Michal Tomcik; Michal Vrablik; Jiri Lastuvka; Pavel Horak; Helena Kaspar Medkova; Anne M Kerola
Journal:  RMD Open       Date:  2021-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.